Michael Nagel's most recent trade in Kiromic BioPharma Inc was a trade of 1,000 Common Stock done at an average price of $3.3 . Disclosure was reported to the exchange on June 11, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kiromic BioPharma Inc | Michael Nagel | Director | Purchase of securities on an exchange or from another person at price $ 3.33 per share. | 11 Jun 2024 | 1,000 | 43,296 | - | 3.3 | 3,330 | Common Stock |
| Kiromic BioPharma Inc | Michael Nagel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 18,000 | 42,296 | - | - | Restricted Stock Award | |
| Kiromic BioPharma Inc | Michael Nagel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 183,600 | 188,878 | - | - | Stock Option (Right to Buy) |